Search company, investor...

Predict your next investment

Venture Capital
greatoaksvc.com

Investments

387

Portfolio Exits

95

Funds

7

About Great Oaks Venture Capital

Great Oaks Venture Capital is a seed-stage investment firm committed to identifying, financing and developing early-stage growth businesses. Based in New York City, GOVC was founded by Andrew Boszhardt, a financial entrepreneur with approximately 35 years of capital market experience. GOVC's typical investment size ranges from $50K to $500K.

Headquarters Location

660 Madison Ave Suite 1600

New York, New York, 10065,

United States

212-821-1800

Want to inform investors similar to Great Oaks Venture Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Expert Collections containing Great Oaks Venture Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Great Oaks Venture Capital in 3 Expert Collections, including Store tech (In-store retail tech).

S

Store tech (In-store retail tech)

55 items

Startups aiming work with retailers to improve brick-and-mortar retail operations.

E

Education Technology (Edtech)

58 items

C

CB Insights Consumer Smart Money Investors - 2020

25 items

Track the world's top-performing VC investors in consumer. Firms are presented in alphabetical order.

Research containing Great Oaks Venture Capital

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Great Oaks Venture Capital in 1 CB Insights research brief, most recently on Jun 11, 2020.

Latest Great Oaks Venture Capital News

Cure: Premium Hydration Company Secures $5.6 Million

Apr 24, 2023

Cure – a functional hydration brand – announced $5.6 million in Series A funding and retail expansion to 15,000 stores nationwide, further cementing the brand as a key player in the $10 billion functional drink mix market. This funding round was led by Lerer Hippeau with additional participation from new and existing investors including Valedor Partners, Simple Food Ventures, Great Oaks Venture Capital, Joyance Partners, Silas Capital, Kim Clijsters, and others. Cure will utilize the funding to accelerate retail expansion, grow its leadership team, enhance customer awareness, and develop new products. Since launching in 2019, Cure has grown an average of 230% every year and expanded its retail footprint to include new retail partners like Sprouts, Albertsons, Kroger, Stop & Shop, Wegmans and HEB, joining existing accounts including CVS and Walgreens. In the past 12 weeks, Cure had grown 316% in the Natural channel compared to the overall category growing at 19.5%, making Cure the fastest-growing natural hydration brand, according to SPINS. Known as the only female-founded electrolyte brand – which is also majority women operated and has an all-female medical and nutritional advisory board – Cure is also the recipient of a 2022 Fitness Award from Women’s Health magazine, and counts Gwyneth Paltrow, Ashley Graham, Brooklyn Decker, and Miranda Kerr among its many celebrity fans. Cure – which is on a mission to empower others to live better and healthier lives – is uniquely positioned to capture a major portion of the $10 billion functional drink mix market by creating science-backed wellness products with clean, effective ingredients at affordable prices. And its plant-based electrolyte powders are based on the World Health Organization’s ORS formula, but unlike other ORS formulas, its ingredients are non-GMO, sustainably sourced, and have no added sugar or erythritol. Plus Cure also launched new electrolyte flavors earlier this year including Lemonade and Strawberry Kiwi, and introduced a new bulk jar format. Cure is continuing to add industry veterans to its leadership team, announcing recently that the company has brought on Laura Kendrick as their Chief Marketing Officer, formerly at Highline Wellness and SmartyPants Vitamins, and Stacey Gillespie as their VP of Innovation, formerly Ora Organic and Gaia Herbs. Cure is backed by a medical advisory board that includes Dr. Roshini Raj, Dr. Dana Cohen, and Brooke Alpert and is FSA/HSA Eligible. And in just over 4 years, Cure has expanded to over 15,000 retail stores nationwide including CVS, Walgreens, Albertsons, and Sprouts. KEY QUOTES: “In the past four years, Cure has seen explosive growth as consumers look for better-for-you functional beverages that really work and aren’t full of added sugar. Cure is on a mission to create healthy and effective products that provide the ultimate foundation for health and well-being.” Lauren Picasso, CEO and founder at Cure Hydration “We are excited to partner with Cure, an omnichannel hydration company we believe is poised for breakout growth in the $10 billion functional drink mix market. After only launching in 2019, the brand has quickly gained traction online and in over 15,000 doors. We believe Cure’s high performance is attributable to its outstanding team, especially CEO and Founder Lauren Picasso whose drive, magnetism and experience bode well for Cure’s future success. We can’t wait to see what Cure accomplishes in the coming years.” Valedor Partners’ Barbara Palmquist “We continue to invest in Cure because the team has proved that they can scale beyond direct-to-consumer to become an omnichannel brand with a national footprint. We are excited to see Cure’s continued retail distribution and disruption of the hydration category.” Caitlin Strandberg, Partner at Lerer Hippeau Trending on Pulse 2.0

Great Oaks Venture Capital Investments

387 Investments

Great Oaks Venture Capital has made 387 investments. Their latest investment was in Triumph Labs as part of their Series A on May 5, 2023.

CBI Logo

Great Oaks Venture Capital Investments Activity

investments chart

Great Oaks Venture Capital Portfolio Exits

95 Portfolio Exits

Great Oaks Venture Capital has 95 portfolio exits. Their latest portfolio exit was Plastiq on May 24, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/24/2023

Asset Sale

$99M

5

5/17/2023

Acquired - II

$99M

1

2/23/2023

Acq - Pending

$99M

2

1/24/2023

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

1/11/2023

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/24/2023

5/17/2023

2/23/2023

1/24/2023

1/11/2023

Exit

Asset Sale

Acquired - II

Acq - Pending

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

5

1

2

10

10

Great Oaks Venture Capital Fund History

7 Fund Histories

Great Oaks Venture Capital has 7 funds, including Springboard SPV IV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/10/2019

Springboard SPV IV

$2.07M

1

8/5/2013

Great Oaks Venture Fund

Subscribe to see more

Subscribe to see more

$99M

10

4/15/2009

Great Oaks Strategic Investment Partners

$99M

10

2/2/2009

Great Oaks Opportunistic Distressed Securities Fund

10

11/1/2007

Great Oaks Strategic Investment Partners II

10

Closing Date

9/10/2019

8/5/2013

4/15/2009

2/2/2009

11/1/2007

Fund

Springboard SPV IV

Great Oaks Venture Fund

Great Oaks Strategic Investment Partners

Great Oaks Opportunistic Distressed Securities Fund

Great Oaks Strategic Investment Partners II

Fund Type

Subscribe to see more

Status

Subscribe to see more

Amount

$2.07M

$99M

$99M

Sources

1

10

10

10

10

Great Oaks Venture Capital Team

3 Team Members

Great Oaks Venture Capital has 3 team members, including current Founder, Managing Partner, Andrew Krebs Boszhardt, Jr..

Name

Work History

Title

Status

Andrew Krebs Boszhardt, Jr.

Founder, Managing Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Andrew Krebs Boszhardt, Jr.

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, Managing Partner

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.